Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)

被引:379
作者
Fishman, Neil
Patterson, Jan
Saiman, Lisa
Srinivasan, Arjun
Trivedi, Kavita K.
van Schooneveld, Trevor
Lynfield, Ruth
Gerding, Dale
Septimus, Edward
Schwartz, David
Daum, Robert
Englund, Janet A.
Harrison, Christopher J.
Bradley, John S.
Newland, Jason
机构
[1] University of Pennsylvania Health System, Philadelphia, PA 19104, 3400 Spruce Street, Penn Tower
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; JOINT-COMMITTEE; GUIDELINES; PREVENTION; IMPACT;
D O I
10.1086/665010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Antimicrobial resistance has emerged as a significant healthcare quality and patient safety issue in the twenty-first century that, combined with a rapidly dwindling antimicrobial armamentarium, has resulted in a critical threat to the public health of the United States. Antimicrobial stewardship programs optimize antimicrobial use to achieve the best clinical outcomes while minimizing adverse events and limiting selective pressures that drive the emergence of resistance and may also reduce excessive costs attributable to suboptimal antimicrobial use. Therefore, antimicrobial stewardship must be a fiduciary responsibility for all healthcare institutions across the continuum of care. This position statement of the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society of America outlines recommendations for the mandatory implementation of antimicrobial stewardship throughout health care, suggests process and outcome measures to monitor these interventions, and addresses deficiencies in education and research in this field as well as the lack of accurate data on antimicrobial use in the United States. Infect Control Hosp Epidemiol 2012; 33(4): 322-327
引用
收藏
页码:322 / 327
页数:6
相关论文
共 37 条
[31]   Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies [J].
Patel, Gopi ;
Huprikar, Shirish ;
Factor, Stephanie H. ;
Jenkins, Stephen G. ;
Calfee, David P. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (12) :1099-1106
[32]   The clinical consequences of antimicrobial resistance [J].
Rice, Louis B. .
CURRENT OPINION IN MICROBIOLOGY, 2009, 12 (05) :476-481
[33]   Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship [J].
Roberts, Rebecca R. ;
Hota, Bala ;
Ahmad, Ibrar ;
Scott, R. Douglas, II ;
Foster, Susan D. ;
Abbasi, Fauzia ;
Schabowski, Shari ;
Kampe, Linda M. ;
Ciavarella, Ginevra G. ;
Supino, Mark ;
Naples, Jeremy ;
Cordell, Ralph ;
Levy, Stuart B. ;
Weinstein, Robert A. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) :1175-1184
[34]   Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals (Reprinted from Infection Control and Hospital Epidemiology, vol 18, pg 275-91, 1997) [J].
Shlaes, DM ;
Gerding, DN ;
John, JF ;
Craig, WA ;
Bornstein, DL ;
Duncan, RA ;
Eckman, MR ;
Farrer, WE ;
Greene, WH ;
Lorian, V ;
Levy, S ;
McGowan, JE ;
Paul, SM ;
Ruskin, J ;
Tenover, FC ;
Watanakunakorn, C .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :584-599
[35]  
Shlaes DM, 1997, INFECT CONT HOSP EP, V18, P275
[36]   QUANTITATIVE ACTION OF PENICILLIN INHIBITOR FROM PENICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI [J].
SPINK, WW ;
FERRIS, V .
SCIENCE, 1945, 102 (2644) :221-223
[37]   Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy [J].
Zavascki, Alexandre P. ;
Carvalhaes, Cecilia G. ;
Picao, Renata C. ;
Gales, Ana C. .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (01) :71-93